Effects of landiolol on mechanical and metabolic changes in rat reperfused ischaemic hearts

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 1-2, 2007, Pages 55-60

  Sakanashi, Makiko ^a   Sakanashi, Mayuko ^a   Sugahara, Kazuhiro ^a   Sakanashi, Matao ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Calcium antagonism; Cardiodynamics; Ischaemia reperfusion; Landiolol; Reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; CREATINE PHOSPHATE; LACTATE DEHYDROGENASE; LANDIOLOL; MALONALDEHYDE; PHOSPHATE; POTASSIUM CHLORIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM ANTAGONISM; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ENZYME RELEASE; HEART ATRIUM PACING; HEART CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; MALE; NONHUMAN; RAT; REPERFUSION;

ADENOSINE TRIPHOSPHATE; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AORTA; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MORPHOLINES; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHATES; PHOSPHOCREATINE; RATS; RATS, WISTAR; UREA; VASODILATION; VASODILATOR AGENTS;

EID: 33846082296     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04543.x     Document Type: Article

References (26)

1. Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 1989; 80: 1115-27.
2. McCord JM, Roy RS, Schaffer SW. Free radicals and myocardial ischemia. The role of xanthine oxidase. Adv. Myocardiol. 1985; 5: 183-9.
3. Xia Y, Khatchikian G, Zweier JL. Adenosine deaminase inhibition prevents free radical-mediated injury in the postischemic heart. J. Biol. Chem. 1996; 271: 10 096-102.
4. Katz AM. Physiology of the Heart, 2nd edn. Raven Press, New York. 1992.
5. Angelos MG, Kutala VK, Torres CA et al. Hypoxic reperfusion of the ischemic heart and oxygen radical generation. Am. J. Physiol. 2006; 290: H341-7.
6. Bolli R. Causative role of oxyradicals in myocardial stunning: A proven hypothesis. A brief review of the evidence demonstrating a major role of reactive oxygen species in several forms of postischemic dysfunction. Basic Res. Cardiol. 1998; 93: 156-62.
7. Freedman AM, Kramer JH, Mak IT, Cassidy MM, Weglicki WB. Propranolol preserves ultrastructure in adult cardiocytes exposed to anoxia/reoxygenation: A morphometric analysis. Free Radic. Biol. Med. 1991; 11: 197-206.
8. Liu XK, Engelman RM, Agrawal HR, Das DK. Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: A novel mechanism of action of beta-blockers. J. Mol. Cell. Cardiol. 1991; 23: 1091-100.
9. Iwai T, Tanonaka K, Kasahara S, Inoue R, Takeo S. Protective effect of propranolol on mitochondrial function in the ischemic heart. Br. J. Pharmacol. 2002; 136: 472-80.
10. Jeroudi MO, Hartley CJ, Bolli R. Myocardial reperfusion injury: Role of oxygen radicals and potential therapy with antioxidants. Am. J. Cardiol. 1994; 73: B2-7.
11. Iguchi S, Iwamura H, Nishizaki M et al. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem. Pharm. Bull. 1992; 40: 1462-9.
12. Kurosawa S, Kanaya N, Niiyama Y, Nakayama M, Fujita S, Namiki A. Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts. Can. J. Anaesth. 2003; 50: 489-94.
13. Roth E, Torok B. Effect of the ultrashort-acting beta-blocker Brevibloc on free-radical-mediated injuries during the early reperfusion state. Basic Res. Cardiol. 1991; 86: 422-33.
14. Daga MK, Chaudhary M, Sharma B et al. Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction. J. Assoc. Physicians India 2003; 51: 677-80.
15. Yasuda T, Kamiya H, Tanaka Y, Watanabe G. Ultra-short-acting cardioselective beta-blockade attenuates postischemic cardiac dysfunction in the isolated rat heart. Eur. J. Cardiothorac. Surg. 2001; 19: 647-52.
16. Koster JF, Slee RG, Essed CE, Stam H. Studies on cumene hydroperoxide-induced lipid peroxidation in the isolated perfused rat heart. J. Mol. Cell. Cardiol. 1985; 17: 701-8.
17. Hara A, Matsumura H, Abiko Y. Lidocaine attenuates both mechanical and metabolic changes induced by hydrogen peroxide in the rat heart. Am. J. Physiol. 1993; 265: H1478-85.
18. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979; 95: 351-8.
19. Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 1925; 66: 375-400.
20. Furchgott RF, De Gubareff T. The determination of inorganic phosphate and creatine phosphate in tissue extracts. J. Biol. Chem. 1956; 223: 377-88.
21. Sakanashi M, Matsuzaki T, Nakasone J et al. Effects of diltiazem on in vitro cardiovascular actions of crude venom obtained from Okinawan box-jellyfish (Habu-kurage), Chiropsalmus quadrigatus. Anaesth. Intensive Care 2002; 30: 570-7.
22. Itomine T, Matsuzaki T, Sakanashi M, Hobara N, Sakanashi M. b-Adrenoceptor blocking activities of nipradilol and its optical isomers in pig coronary artery. Clin. Exp. Pharmacol. Physiol. 2001; 28: 271-7.
23. Aniya Y, Fong KF, Naito A, Sakanashi M. Antioxidative action of the beta-adrenoceptor antagonist bopindolol and its metabolite 18-502. Jpn. J. Pharmacol. 1995; 68: 323-9.
24. Aruoma OI, Smith C, Cecchini R, Evans PJ, Halliwell B. Free radical scavenging and inhibition of lipid peroxidation by beta-blockers and by agents that interfere with calcium metabolism. A physiologically-significant process? Biochem. Pharmacol. 1991; 42: 735-43.
25. Fleckenstein A. Calcium Antagonism in Heart and Smooth Muscle. John Wiley & Sons, New York. 1983.
26. Setoguchi M, Ohya Y, Abe I, Fujishima M. Inhibitory action of betaxolol, a beta 1-selective adrenoceptor antagonist, on voltage-dependent calcium channels in guinea-pig artery and vein. Br. J. Pharmacol. 1995; 115: 198-202.